APG808 is an anti-human IL-4Ralpha monoclonal antibody. APG808 binds to IL-4Ralpha, prevents IL-13Ralpha1/IL-4Ralpha heterodimer formation, and disrupts IL-13 and IL-4 mediated signaling. APG808 ablates Fc and complement effector functions. APG808 can be used for the research of chronic obstructive pulmonary disease, asthma, atopic dermatitis[1].
Target:
Interleukin Related
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted
